Premium Nahrungsergänzungsmittel | artgerecht

Tilidine – Effects, Dosage and Side Effects

Tilidine is a prescription opioid analgesic used to treat moderate to severe pain. It acts centrally in the brain and spinal cord and is commonly combined with naloxone.

Regular tips about health Regular tips about health

Things worth knowing about "Tilidine"

Tilidine is a prescription opioid analgesic used to treat moderate to severe pain. It acts centrally in the brain and spinal cord and is commonly combined with naloxone.

What is Tilidine?

Tilidine is a potent opioid analgesic used for the management of moderate to severe pain that cannot be adequately controlled with weaker pain medications. In Germany, tilidine is a controlled substance under the Narcotics Act (BtMG) and is routinely prescribed in combination with naloxone to reduce its potential for misuse and abuse.

Mechanism of Action

Tilidine itself is a prodrug, meaning it has limited pharmacological activity in its original form. After oral ingestion, it is rapidly metabolized in the liver into its active form, nortilidine. Nortilidine binds to opioid receptors in the brain and spinal cord, primarily the mu-opioid receptors. This binding inhibits the transmission of pain signals and significantly reduces the perception of pain.

The naloxone component included in combination products is an opioid antagonist that blocks opioid effects. When taken orally, naloxone undergoes extensive first-pass metabolism in the liver and therefore has minimal systemic effect. However, if the medication is administered intravenously in an attempt to misuse it, naloxone effectively blocks the analgesic effects of tilidine, thereby discouraging injection abuse.

Indications

Tilidine is primarily indicated for the following types of pain:

Severe acute pain, such as postoperative pain or pain from injury
Chronic pain, including cancer-related pain, back pain, or neuropathic pain
Pain that does not respond adequately to non-opioid analgesics

Dosage Forms and Dosing

Tilidine is available in several dosage forms:

Extended-release tablets: designed for steady pain control in chronic conditions
Oral drops: allow flexible dosing, particularly for acute pain management

Dosing is determined individually by the treating physician based on pain severity, body weight, and individual patient factors. Typical adult doses range from 50 to 100 mg tilidine every 4 to 6 hours, adjusted accordingly for extended-release formulations. The medication should always be taken as directed by a healthcare professional.

Side Effects

As with all opioids, tilidine can cause side effects. Common side effects include:

Nausea and vomiting
Dizziness and lightheadedness
Fatigue and sedation
Constipation
Headache

Less common but serious side effects may include:

Respiratory depression (slow, shallow breathing), especially in cases of overdose
Physical and psychological dependence with prolonged use
Cardiovascular effects such as low blood pressure

Drug Interactions

Tilidine may interact with a number of other medications. Special caution is advised when combined with:

Other central nervous system depressants such as sedatives, sleep aids, or alcohol – combined effects may lead to dangerous sedation or respiratory depression
MAO inhibitors (certain antidepressants) – concurrent use is contraindicated
CYP3A4 inhibitors or inducers – these may alter the metabolism of tilidine

Contraindications

Tilidine should not be used in patients with:

Known hypersensitivity to tilidine or naloxone
Severe respiratory depression or significant lung disease
Acute abdomen (e.g., appendicitis)
Pregnancy and breastfeeding (only after strict benefit-risk assessment)
Children under 14 years of age (drops) or under 18 years of age (extended-release tablets)

Dependence and Misuse

As an opioid, tilidine carries a risk of physical and psychological dependence, particularly with long-term use. Therapy duration should therefore be kept as short as clinically necessary. Abrupt discontinuation after prolonged use can lead to withdrawal symptoms, so gradual tapering under medical supervision is strongly recommended.

References

Federal Institute for Drugs and Medical Devices (BfArM): Summary of Product Characteristics for Tilidine/Naloxone, current edition.
Lüllmann H, Mohr K, Hein L: Pharmacology and Toxicology. 18th edition, Thieme Publishers, 2016.
World Health Organization (WHO): WHO Model List of Essential Medicines, 23rd edition, 2023.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.